[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |

2015-2019 Global AFP Diagnostics Market: US, Europe, Japan - Emerging Opportunities and Business Strategies - Competitive Landscape, Supplier Shares, Country Volume and Sales Segment Forecasts

July 2015 | 248 pages | ID: 29702502148EN
Venture Planning Group

US$ 3,480.00 US$ 4,350.00 -20 %

E-mail Delivery (PDF)

Download PDF Leaflet

Accepted cards
Wire Transfer
Checkout Later
Need Help? Ask a Question
The cancer diagnostics market is on the verge of explosion, as the researchers approach major technological breakthroughs in tumor diagnosis and therapy, discover new specific antigens, and unlock the mystery of the genetic basis of the disease.

During the next ten years, the worldwide cancer testing market is promising to be an exciting, dynamic and rapidly expanding field. Anticipated technological breakthroughs will create numerous opportunities for determining genetic predisposition, detecting specific tumors, and monitoring biological response to cancer therapy. The rise in geriatric population will further compound the growing demand for malignancy assays and the rapid market expansion worldwide.

This report presents a detailed analysis of the Alpha-fetoprotein testing market in the US, Europe (France, Germany, Italy, Spain, UK) and Japan, including clinical significance and current laboratory practice; 5- and 10-year test volume and sales forecasts by country and market segment; as well as sales and market shares for major suppliers.

The report also examines market applications of DNA probes, biochips/microarrays, monoclonal antibodies, immunoassays, IT, chromosome analysis, and other technologies; reviews features and operating characteristics of automated analyzers; profiles leading suppliers and recent market entrants developing innovative technologies and products; and identifies alternative market penetration strategies and entry barriers/risks.

Contains 248 pages and 14 tables
I. INTRODUCTION

II. AFP WORLDWIDE MARKET AND TECHNOLOGY OVERVIEW

A. Alpha - Fetoprotein (AFP): Clinical Significance and Laboratory Practices
B. Instrumentation Review And Market Needs
  1. Abbott AxSYM
  2. Abbott Architect c 4000
  3. Abbott Architect i 2000 Series
  4. Abbott Architect ci 8200 System
  5. Beckman Coulter UniCel Series
  6. Beckman Coulter Access
  7. Binding Site ESP 600
  8. bioMerieux Mini Vidas
  9. Carolina Chemistries BioLis 24i
  10. DiaSorin Liaison
  11. Horiba ABX Pentra 400
  12. Inverness DS
  13. J&J Vitros ECi/ECiQ
  14. J&J Vitros 3600
  15. J&J Vitros 5600
  16. Olympus AU 5400
  17. Olympus AU 3000i
  18. Olympus AU 2700
  19. Roche Modular Analytics
  20. Roche Cobas Integra 400
  21. Roche Cobas Integra 400 Plus
  22. Roche Elecsys
  23. Roche Cobas c311
  24. Siemens ADVIA Centaur
  25. Siemens Dimension
  26. Siemens Dimension RxL Max
  27. Siemens Dimension Vista 500
  28. Siemens Immulite
  29. Siemens Stratus
  30. Tosoh AIA - Series
  31. Vital Diagnostics ATAC 8000
  32. Vital Diagnostics Envoy 500
C. Current and Emerging Technologies
  1. Monoclonal and Polyclonal Antibodies
  2. Immunoassays
    a. Technological Principle
    b. Radioimmunoassay (RIA)
    c. Enzyme Immunoassays (EIA)
     Overview
     ELISA
     Immunofiltration
     Particle - Membrane Capture Immunoassay
     Enzyme Amplification
    d. Fluorescent Immunoassays
    e. Luminescence
     Chemiluminescence
     Bioluminescence
    f. Latex Agglutination
    g. Immunoprecipitation
H. Affinity Chromatographu
    e. Liposome Flow - Injection Immunoassay
  3. Molecular Diagnostics
    a. Technology Overview
    b. Amplification Methods
     PCR
     DAP - PCR
     Immuno - PCR
     QC - PCR
     CAR
     DNA
     HPA
     LCR
     NASBA
     QBR
     SDA
     3 SR, and others
  4. Chromosome Analysis
    a. Chronic Myelogenous Leukemia (CML)
    b. Acute Myeloid Leukemia (AML)
    c. Acute Lymphoblastic Leukemia (ALL)
    d. Malignant Lymphomas Lymphoid Malignancies
    e. Chronic Lymphocytic Leukemia (CLL)
    f. Solid Cancers
    g. Chromosomal Translocation and Oncogenes
  5. Artificial Intelligence
  6. Flow Cytometry
  7. Two Dimensional Gel Electrophoresis (  2 - DGE)
  8. Biosensors
  9. Competing/Complementing Technologies
    a. CT
    b. MRI
    c. NMR
    d. PET
    e. Photonics Spectroscopy
E. Personal Testing

III. FRANCE: MARKET SIZE, GROWTH AND MAJOR SUPPLIERS’ SALES AND MARKET SHARES

IV. GERMANY: MARKET SIZE, GROWTH AND MAJOR SUPPLIERS’ SALES AND MARKET SHARES

V. ITALY: MARKET SIZE, GROWTH AND MAJOR SUPPLIERS’ SALES AND MARKET SHARES

VI. JAPAN: MARKET SIZE, GROWTH AND MAJOR SUPPLIERS’ SALES AND MARKET SHARES

VII. SPAIN: MARKET SIZE, GROWTH AND MAJOR SUPPLIERS’ SALES AND MARKET SHARES

VIII. U.K.: TEST VOLUME AND DIAGNOSTICS SALES FORECAST BY MARKET SEGMENT

IX. U.S.A.: MARKET SIZE, GROWTH AND MAJOR SUPPLIERS’ SALES AND MARKET SHARES

X. DESIGN CRITERIA FOR DECENTRALIZED TESTING PRODUCTS

XI. ALTERNATIVE MARKET PENETRATION STRATEGIES

A. Internal Development
B. Collaborative Arrangements
C. University Contracts
D. Distribution Strategies
  1. Marketing Approaches
  2. Product Complexity
  3. Customer Preference
  4. Established Suppliers
  5. Emerging Suppliers
  6. Major Types of Distributors
  7. Market Segmentation Factor

XII. POTENTIAL MARKET ENTRY BARRIERS AND RISKS

A. Market Maturity
B. Cost Containment
C. Competition
D. Technological Edge and Limitations
E. Patent Protection
F. Regulatory Constraints
G. Decentralized Testing Market Challenges

XIII. COMPETITIVE PROFILES

Abbott
AdnaGen
Applied Gene Technologies
Arca Biopharma
Beckman Coulter/Danaher
Becton Dickinson
Biomedical Diagnostics
bioMerieux
Bio - Rad
Cepheid
Correlogic Systems
Decode Genetics
Diadexus
Diagnocure
Diasorin
Eiken Chemical
Elitech Group
Enterix
Enzo Biochem
Epigenomics
Exact Sciences
Fujirebio
Hologic/Gen - Probe
Guided Therapeutics
Kreatech/Leica
Kyowa Medex
Mackay Life Sciences
Myriad Genetics
OncoLab
Ortho - Clinical Diagnostics
Panacea Pharmaceuticals
Polartechnics
Polymedco
PreMD
Qiagen
Quest Diagnostics
Radient Pharmaceuticals
Roche
Scienion
Sequenom
Siemens Healthcare
Takara Bio
Targeted Diagnostics & Therapeutics
Thermo Fisher
Tosoh
Veridex
Wako Pure Chemicals
Wallac/PE
Zila

LIST OF TABLES

Major Companies Developing or Marketing AFP Tests
France AFP Test Volume and Diagnostics Sales by Market Segment
France AFP Testing Market by Major Supplier
Germany AFP Test Volume and Diagnostics Sales by Market Segment
Germany AFP Testing Market by Major Supplier
Italy AFP Test Volume and Diagnostics Sales by Market Segment
Italy AFP Testing Market by Major Supplier
Japan AFP Test Volume and Diagnostics Sales by Market Segment
Japan AFP Testing Market by Major Supplier
Spain AFP Test Volume and Diagnostics Sales by Market Segment
Spain AFP Testing Market by Major Supplier
U.K. AFP Test Volume and Diagnostics Sales by Market Segment
U.S.A. AFP Test Volume and Diagnostics Sales by Market Segment
U.S.A. AFP Testing Market by Major Supplier


More Publications